Concepts (135)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HIV-1 | 12 | 2023 | 221 | 1.970 |
Why?
|
| Astrocytes | 11 | 2023 | 141 | 1.830 |
Why?
|
| beta Catenin | 11 | 2022 | 59 | 1.670 |
Why?
|
| HIV Infections | 11 | 2023 | 457 | 1.370 |
Why?
|
| Gene Expression Regulation, Viral | 2 | 2013 | 12 | 0.540 |
Why?
|
| Wnt Signaling Pathway | 4 | 2022 | 33 | 0.510 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 2 | 2014 | 13 | 0.500 |
Why?
|
| CD8-Positive T-Lymphocytes | 4 | 2022 | 103 | 0.500 |
Why?
|
| Virus Latency | 2 | 2022 | 15 | 0.490 |
Why?
|
| Transcription Factors | 2 | 2014 | 158 | 0.470 |
Why?
|
| Epigenesis, Genetic | 1 | 2013 | 75 | 0.430 |
Why?
|
| Anti-HIV Agents | 2 | 2023 | 69 | 0.390 |
Why?
|
| Transcriptional Activation | 1 | 2011 | 30 | 0.390 |
Why?
|
| Virus Replication | 4 | 2021 | 49 | 0.360 |
Why?
|
| Gene Expression Regulation | 3 | 2020 | 262 | 0.340 |
Why?
|
| Brain | 4 | 2022 | 1560 | 0.340 |
Why?
|
| Leukocytes, Mononuclear | 5 | 2023 | 53 | 0.340 |
Why?
|
| CD4 Antigens | 2 | 2022 | 27 | 0.330 |
Why?
|
| AIDS Dementia Complex | 2 | 2017 | 38 | 0.250 |
Why?
|
| HIV Long Terminal Repeat | 3 | 2013 | 14 | 0.240 |
Why?
|
| Signal Transduction | 4 | 2017 | 410 | 0.240 |
Why?
|
| CD8 Antigens | 2 | 2022 | 11 | 0.230 |
Why?
|
| Cell Movement | 2 | 2022 | 70 | 0.230 |
Why?
|
| Cells, Cultured | 5 | 2023 | 495 | 0.220 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2023 | 19 | 0.220 |
Why?
|
| TCF Transcription Factors | 2 | 2020 | 10 | 0.210 |
Why?
|
| Humans | 19 | 2023 | 25692 | 0.210 |
Why?
|
| Wnt Proteins | 2 | 2020 | 22 | 0.200 |
Why?
|
| Viral Tropism | 1 | 2022 | 2 | 0.200 |
Why?
|
| Zika Virus Infection | 1 | 2021 | 3 | 0.190 |
Why?
|
| Zika Virus | 1 | 2021 | 3 | 0.190 |
Why?
|
| Animals | 8 | 2023 | 3510 | 0.190 |
Why?
|
| Fetus | 1 | 2021 | 37 | 0.190 |
Why?
|
| Activating Transcription Factor 2 | 1 | 2020 | 3 | 0.180 |
Why?
|
| Interleukin-8 | 1 | 2020 | 17 | 0.180 |
Why?
|
| Immunity, Cellular | 1 | 2020 | 29 | 0.180 |
Why?
|
| Hepatocyte Nuclear Factors | 1 | 2020 | 3 | 0.180 |
Why?
|
| Glycoproteins | 1 | 2020 | 43 | 0.170 |
Why?
|
| DNA Virus Infections | 1 | 2020 | 4 | 0.170 |
Why?
|
| RNA Virus Infections | 1 | 2020 | 4 | 0.170 |
Why?
|
| RNA Viruses | 1 | 2020 | 4 | 0.170 |
Why?
|
| Salicylates | 1 | 2020 | 6 | 0.170 |
Why?
|
| DNA Viruses | 1 | 2020 | 6 | 0.170 |
Why?
|
| Viral Envelope Proteins | 1 | 2020 | 15 | 0.170 |
Why?
|
| Mice | 6 | 2023 | 1345 | 0.170 |
Why?
|
| Interleukin-6 | 1 | 2020 | 74 | 0.170 |
Why?
|
| Viral Fusion Proteins | 1 | 2020 | 15 | 0.170 |
Why?
|
| Antiviral Agents | 1 | 2020 | 66 | 0.160 |
Why?
|
| Cell Line, Tumor | 3 | 2020 | 221 | 0.160 |
Why?
|
| Macrophages | 2 | 2022 | 97 | 0.150 |
Why?
|
| Cell Line | 2 | 2020 | 268 | 0.150 |
Why?
|
| Methamphetamine | 1 | 2017 | 22 | 0.140 |
Why?
|
| Central Nervous System Stimulants | 1 | 2017 | 37 | 0.140 |
Why?
|
| Glutamic Acid | 1 | 2016 | 25 | 0.130 |
Why?
|
| Substance-Related Disorders | 1 | 2017 | 87 | 0.130 |
Why?
|
| Transcription Factor 4 | 2 | 2014 | 6 | 0.130 |
Why?
|
| CD4-Positive T-Lymphocytes | 3 | 2022 | 100 | 0.120 |
Why?
|
| Neurons | 1 | 2017 | 315 | 0.120 |
Why?
|
| Leukocytes | 1 | 2014 | 35 | 0.110 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2013 | 3 | 0.110 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2013 | 6 | 0.110 |
Why?
|
| Histone Deacetylases | 1 | 2013 | 9 | 0.110 |
Why?
|
| Virus Integration | 1 | 2013 | 8 | 0.110 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2014 | 22 | 0.110 |
Why?
|
| Mice, Inbred NOD | 3 | 2022 | 25 | 0.110 |
Why?
|
| Mice, SCID | 3 | 2022 | 37 | 0.110 |
Why?
|
| Monocytes | 1 | 2014 | 53 | 0.110 |
Why?
|
| Promoter Regions, Genetic | 1 | 2013 | 89 | 0.110 |
Why?
|
| Transcription, Genetic | 1 | 2013 | 100 | 0.110 |
Why?
|
| Estradiol | 1 | 2013 | 33 | 0.110 |
Why?
|
| Estrogen Receptor alpha | 1 | 2013 | 15 | 0.110 |
Why?
|
| Gene Expression Profiling | 1 | 2013 | 128 | 0.110 |
Why?
|
| Piperazines | 1 | 2013 | 75 | 0.110 |
Why?
|
| Molecular Sequence Data | 1 | 2011 | 169 | 0.100 |
Why?
|
| Vero Cells | 2 | 2021 | 8 | 0.090 |
Why?
|
| Virus Internalization | 2 | 2021 | 17 | 0.090 |
Why?
|
| Interleukin Receptor Common gamma Subunit | 2 | 2022 | 5 | 0.080 |
Why?
|
| Mice, Knockout | 2 | 2015 | 284 | 0.060 |
Why?
|
| Lamivudine | 1 | 2023 | 9 | 0.050 |
Why?
|
| Cost-Benefit Analysis | 1 | 2023 | 124 | 0.050 |
Why?
|
| Cell Differentiation | 1 | 2023 | 127 | 0.050 |
Why?
|
| Disease Models, Animal | 2 | 2017 | 584 | 0.050 |
Why?
|
| CX3C Chemokine Receptor 1 | 1 | 2022 | 2 | 0.050 |
Why?
|
| Receptors, Lymphocyte Homing | 1 | 2022 | 2 | 0.050 |
Why?
|
| Proviruses | 1 | 2022 | 3 | 0.050 |
Why?
|
| Receptors, CXCR3 | 1 | 2022 | 4 | 0.050 |
Why?
|
| Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination | 1 | 2022 | 4 | 0.050 |
Why?
|
| Virus Activation | 1 | 2022 | 12 | 0.050 |
Why?
|
| Mitochondria | 1 | 2022 | 62 | 0.050 |
Why?
|
| Apoptosis | 1 | 2022 | 177 | 0.050 |
Why?
|
| DNA Replication | 1 | 2020 | 10 | 0.040 |
Why?
|
| Kidney | 1 | 2021 | 155 | 0.040 |
Why?
|
| Virion | 1 | 2020 | 14 | 0.040 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2020 | 52 | 0.040 |
Why?
|
| DNA, Viral | 1 | 2020 | 37 | 0.040 |
Why?
|
| HEK293 Cells | 1 | 2020 | 62 | 0.040 |
Why?
|
| Male | 3 | 2020 | 13917 | 0.040 |
Why?
|
| Animals, Genetically Modified | 1 | 2017 | 18 | 0.040 |
Why?
|
| Primary Cell Culture | 1 | 2017 | 23 | 0.040 |
Why?
|
| Cellular Senescence | 1 | 2017 | 17 | 0.040 |
Why?
|
| Microfilament Proteins | 1 | 2017 | 22 | 0.040 |
Why?
|
| Calcium-Binding Proteins | 1 | 2017 | 24 | 0.040 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2017 | 17 | 0.040 |
Why?
|
| Quality of Life | 1 | 2022 | 600 | 0.040 |
Why?
|
| Excitatory Amino Acid Transporter 2 | 1 | 2016 | 2 | 0.030 |
Why?
|
| Morpholinos | 1 | 2016 | 3 | 0.030 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2016 | 18 | 0.030 |
Why?
|
| Transfection | 1 | 2016 | 112 | 0.030 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2016 | 42 | 0.030 |
Why?
|
| RNA, Small Interfering | 1 | 2016 | 72 | 0.030 |
Why?
|
| Lysosomal-Associated Membrane Protein 1 | 1 | 2015 | 3 | 0.030 |
Why?
|
| Lysosomal-Associated Membrane Protein 2 | 1 | 2015 | 3 | 0.030 |
Why?
|
| Heterografts | 1 | 2015 | 12 | 0.030 |
Why?
|
| Spleen | 1 | 2015 | 32 | 0.030 |
Why?
|
| Rats | 1 | 2017 | 649 | 0.030 |
Why?
|
| RNA, Messenger | 1 | 2016 | 284 | 0.030 |
Why?
|
| DNA-Binding Proteins | 1 | 2017 | 249 | 0.030 |
Why?
|
| Lymphocyte Activation | 1 | 2015 | 78 | 0.030 |
Why?
|
| Adult | 2 | 2020 | 7336 | 0.030 |
Why?
|
| HLA-DR Antigens | 1 | 2014 | 11 | 0.030 |
Why?
|
| Culture Media, Conditioned | 1 | 2014 | 17 | 0.030 |
Why?
|
| STAT3 Transcription Factor | 1 | 2014 | 15 | 0.030 |
Why?
|
| HIV | 1 | 2014 | 40 | 0.030 |
Why?
|
| Interferon-gamma | 1 | 2014 | 75 | 0.030 |
Why?
|
| Leukocyte Transfusion | 1 | 2014 | 4 | 0.030 |
Why?
|
| Receptors, Interleukin-2 | 1 | 2014 | 7 | 0.030 |
Why?
|
| Neoplasms, Experimental | 1 | 2014 | 8 | 0.030 |
Why?
|
| HCT116 Cells | 1 | 2014 | 11 | 0.030 |
Why?
|
| Anti-Retroviral Agents | 1 | 2014 | 13 | 0.030 |
Why?
|
| Adoptive Transfer | 1 | 2014 | 26 | 0.030 |
Why?
|
| Carcinogenesis | 1 | 2014 | 24 | 0.030 |
Why?
|
| Cell Proliferation | 1 | 2014 | 167 | 0.030 |
Why?
|
| Female | 2 | 2020 | 14273 | 0.020 |
Why?
|
| Adolescent | 1 | 2013 | 2076 | 0.020 |
Why?
|
| Young Adult | 1 | 2013 | 1855 | 0.020 |
Why?
|